focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

Share Price Information for Pressure Tech (PRES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 37.50
Bid: 36.00
Ask: 39.00
Change: 0.00 (0.00%)
Spread: 3.00 (8.333%)
Open: 37.50
High: 38.00
Low: 37.50
Prev. Close: 37.50
PRES Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full-Year Trading Update

27 Sep 2022 07:00

RNS Number : 7017A
Pressure Technologies PLC
27 September 2022
 

Pressure Technologies plc

("Pressure Technologies" or the "Group")

 

Full-Year Trading Update

 

Pressure Technologies (AIM: PRES), the specialist engineering group, provides a trading update for the 52 weeks ending 1 October 2022.

The results for the first half of the year, which were announced on 28 June 2022, indicated an adjusted operating loss1 of £2.1 million for the first half, but with a much stronger performance expected for the second half of the year, on the basis of a strong order book in the Chesterfield Special Cylinders division and an expected recovery in order intake in the Precision Machined Components division. However, whilst the second half of the year is expected to show an adjusted operating profit1, the recovery has been significantly below that anticipated at the half year and the Group is now expecting to report an adjusted operating loss for the full year.

Chesterfield Special Cylinders (CSC)

In CSC, progress on major defence contracts in the fourth quarter was impacted by a combination of unexpected customer delays, supply chain disruption and the unplanned outage of key equipment, delaying significant revenue into the first half of FY23. Similarly, several Integrity Management deployments planned for the second half have been delayed by customers into FY23 and beyond. Input costs from raw materials and energy-intensive processes increased significantly throughout the year, further impacting margins where the costs could not be recovered through price escalations and permitted contract variations within the period.

However, the outlook for CSC in FY23 remains positive, supported by an order book of £5.9 million, major defence contract placements expected in the first quarter, and a strong pipeline of defence contracts, Integrity Management deployments and hydrogen storage and transportation projects.

Hydrogen revenue for FY22 is expected to be £2.7 million (2021: £2.2 million) and the current opportunities pipeline underpins confidence in further significant hydrogen revenue growth in FY23, weighted towards the second half of the year.

Precision Machined Components (PMC)

In PMC, there was an unexpected slowdown in order placement from oil and gas customers over the summer period, which recovered later in the fourth quarter. Together with supply chain delays and cost increases, the temporary slowdown resulted in lower revenue and a significantly greater adjusted operating loss1 than anticipated for the full year.

Order intake since the summer holiday period has been strong and the PMC order book at the beginning of FY23 is expected to be around £3.3 million (2021: £1.8 million). OEM customers forecast continued recovery in demand for specialised components for oil and gas exploration and production projects into 2023 and beyond. This is reflected in the expected fourth quarter FY22 order intake of around £3.0 million, the highest quarterly intake since April 2020. The Board now expects PMC to return to profitability in the second quarter of FY23.

Banking Facilities

The Group's revolving credit facility with Lloyds Bank currently runs to 30 June 2023 and at the end of FY22 is expected to be fully drawn at £2.4 million (2 October 2021: £4.8 million drawn). The net debt position, which includes asset finance and right of use lease liabilities, at the end of FY22 is expected to be around £3.9 million (2 October 2021: £4.9 million).

As a result of the expected adjusted operating loss for the full year, the Group now anticipates that it will not be able to meet the requirements of the two existing financial covenants contained within the current facility. These covenants relate to leverage and interest cover and a first test is currently required at the end of October based on full-year performance to 30 September 2022. The Group is currently in constructive dialogue with Lloyds Bank regarding these covenants and ongoing facility requirements.

Ernst & Young LLP continues to support the Group with the review of funding options to replace the Lloyds Bank facility with new arrangements that provide increased liquidity, greater flexibility and the required working capital to support the Group's strategic investment in CSC, in particular for growth opportunities in hydrogen energy.

Outlook

Notwithstanding the disappointing trading performance for FY22, the Board is confident in underlying market opportunities and expects a return to profitability and positive cash generation in FY23. The positive outlook for the Group in the medium and longer term is underpinned by a strong defence orderbook and pipeline, the completion of projects deferred from FY22, improving order placement in PMC over recent weeks and exciting opportunities in hydrogen storage and transportation.

1 Adjusted operating profit/(loss) is operating profit/(loss) before amortisation, impairments and other exceptional costs

For further information, please contact:

Pressure Technologies plc

Chris Walters, Chief Executive

James Locking, Chief Financial Officer

Tel: 0330 015 0710

PressureTechnologies@houston.co.uk

Singer Capital Markets (Nomad and Broker)

Mark Taylor / Asha Chotai

Tel: 0207 496 3000

Houston (Financial PR and Investor Relations)

Kay Larsen / Ben Robinson

Tel: 0204 529 0549

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

COMPANY DESCRIPTION

 

www.pressuretechnologies.com

 

With its head office in Sheffield, the Pressure Technologies Group was founded on its leading market position as a designer and manufacturer of high-integrity, safety-critical components and systems serving global supply chains in oil and gas, defence, industrial and hydrogen energy markets.

 

The Group has two divisions, Chesterfield Special Cylinders and Precision Machined Components.

 

Chesterfield Special Cylinders (CSC) -  www.chesterfieldcylinders.com  

● Chesterfield Special Cylinders, Sheffield, includes CSC Deutschland GmbH.

 

Precision Machined Components (PMC) -  www.pt-pmc.com

● Precision Machined Components includes the Al-Met, Roota Engineering and Martract sites.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFVRAAIRFIF
Date   Source Headline
23rd Nov 20169:49 amRNSChange of Registrar
11th Oct 20162:09 pmRNSGrant of Share Options
10th Oct 20161:40 pmRNSNotice to Shareholders in accordance with FRS 101
30th Aug 20167:00 amRNSUpdate on Recent Trading
3rd Aug 20164:27 pmRNSGrant of Share Options
14th Jun 20167:00 amRNSHalf-year Report
27th Apr 20167:00 amRNSUpdate on Recent Trading
2nd Mar 20162:05 pmRNSExercise of Options
17th Feb 20161:14 pmRNSResult of AGM
17th Feb 20167:00 amRNSAGM Statement
11th Feb 20167:00 amRNSUpdate on investigation into fatality
26th Jan 20161:45 pmRNSCapital Markets Day
22nd Jan 20163:42 pmRNSIssue of Equity
15th Jan 201610:50 amRNSIssue of Equity
8th Jan 20163:05 pmRNSPublication of Annual Report and Notice of AGM
23rd Dec 20157:00 amRNSGrant of Share Options
23rd Dec 20157:00 amRNSExercise of Options
15th Dec 20157:00 amRNSFinal Results
17th Nov 20157:00 amRNSExercise of Options
10th Nov 20157:00 amRNSFull Year Trading Update
5th Oct 201510:22 amRNSHolding(s) in Company
5th Oct 20157:00 amRNSDirector Shareholding
1st Oct 20155:20 pmRNSExercise of Options
29th Sep 20152:30 pmRNSExercise of Options
11th Sep 20157:00 amRNSEXERCISE OF OPTIONS
2nd Sep 20157:00 amRNSIssue of Equity
27th Aug 20157:01 amRNSDirectorate Change
30th Jul 20151:18 pmRNSGrant of Share Options
25th Jun 20154:00 pmRNSGrant of Share Options
16th Jun 20157:01 amRNSDirectorate Change
16th Jun 20157:00 amRNSHalf Yearly Report
15th Jun 20157:00 amRNSChange of Adviser
4th Jun 20157:00 amRNSUpdate on Trading and Notice of Interim Results
27th May 20159:40 amRNSHolding(s) in Company
8th Apr 20153:25 pmRNSHolding(s) in Company
7th Apr 201511:13 amRNSHolding(s) in Company
2nd Apr 20153:47 pmRNSHolding(s) in Company
6th Mar 20153:48 pmRNSHolding(s) in Company
12th Feb 20154:20 pmRNSResult of AGM
5th Feb 20157:00 amRNSUpdate on Trading and Prospects
30th Jan 20153:14 pmRNSTotal Voting Rights
22nd Jan 20159:00 amRNSHolding(s) in Company
19th Jan 20157:00 amRNSProperty Acquisition
23rd Dec 20143:50 pmRNSIssue of Equity
19th Dec 20143:46 pmRNSPublication of Annual Accounts
19th Dec 20143:39 pmRNSHolding(s) in Company
15th Dec 20147:30 amRNSGrant of Share Options
9th Dec 20147:00 amRNSFinal Results
28th Nov 20147:00 amRNSTotal Voting Rights
27th Nov 201411:21 amRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.